Adult growth hormone replacement: Lessons learned and future direction

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 10, 2002, Pages 4427-4428

  Murray, R D ^a   Shalet, S M ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; PLACEBO; SOMATOMEDIN;

ADULT; BODY MASS; BONE DENSITY; BONE MINERAL; DOSE RESPONSE; DRUG EFFECT; DRUG USE; HORMONE SUBSTITUTION; HUMAN; HYPOPITUITARISM; PRIORITY JOURNAL; SHORT SURVEY; SIDE EFFECT;

ADULT; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; INSULIN-LIKE GROWTH FACTOR I; RANDOMIZED CONTROLLED TRIALS;

EID: 0036776240     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-020430     Document Type: Short Survey

References (17)

1. Jorgensen JO, Pedersen SA, Thuesen L, Jorgensen J, Ingemann Hansen T, Skakkebaek NE, Christiansen JS 1989 Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1:1221-1225
2. Salomon F, Cuneo RC, Hesp R, Sonksen PH 1989 The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 321:1797-1803
3. Rosen T, Bengtsson BA 1990 Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336:285-288
4. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM 2001 Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357:425-431
5. Rosen T, Wilhelmsen L, Landin Wilhelmsen K, Lappas G, Bengtsson BA 1997 Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. Eur J Endocrinol 137:240-245
6. Iranmanesh A, Lizarralde G, Veldhuis JD 1991 Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab 73:1081-1088
7. Growth-Hormone-Research-Society 1998 Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: Summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J Clin Endocrinol Metab 83:379-381
8. Baum HB, Biller BM, Finkelstein JS, Cannistraro KB, Oppenhein DS, Schoenfeld DA, Michel TH, Wittink H, Klibanski A 1996 Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial. Ann Intern Med 125:883-890
9. Baum HBA, Katznelson L, Sherman JC, Biller BMK, Hayden DL, Schoenfeld DA, Cannistraro KE, Klibanski A 1998 Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency. J Clin Endocrinol Metab 83:3184-3189
10. Sesmilo G, Biller BM, Llevadot J, Hayden D, Hanson G, Rifai N, Klibanski A 2000 Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial. Ann Intern Med 133:111-122
11. Drake WM, Coyte D, Camacho Hubner C, Jivanji NM, Kaltsas G, Wood DF, Trainer PJ, Grossman AB, Besser GM, Monson JP 1998 Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults. J Clin Endocrinol Metab 83:3913-3919
12. Murray RD, Skillicorn CJ, Howell SJ, Lissett CA, Rahim A, Shalet SM 1999 Dose titration and patient selection increases the efficacy of GH replacement in GHD adults. Clin Endocrinol (Oxf) 50:749-757
13. Murray RD, Adams JE, Smethurst LE, Shalet SM 2002 Spinal irradiation impairs the osteo-anabolic effects of low-dose growth hormone replacement in adults with childhood-onset GH deficiency. Clin Endocrinol (Oxf) 56:169-174
14. Florakis D, Hung V, Kaltsas G, Coyte D, Jenkins PJ, Chew SL, Grossman AB, Besser GM, Monson JP 2000 Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: A two year study. Clin Endocrinol (Oxf) 53:453-459
15. Ahmad AM, Hopkins MT, Thomas J, Ibrahim H, Fraser WD, Vora JP 2001 Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement. Clin Endocrinol (Oxf) 54:709-717
16. Murray RD, Wieringa GE, Lissett CA, Darzy KH, Smethurst LE, Shalet SM 2002 Low-dose GH replacement improves the adverse lipid profile associated with the adult GH deficiency syndrome. Clin Endocrinol (Oxf) 56:525-532
17. Holmes SJ, Shalet SM 1995 Factors influencing the desire for long-term growth hormone replacement in adults. Clin Endocrinol (Oxf) 43:151-157